[Form 4] Perfect Moment Ltd. Insider Trading Activity

Rhea-AI Filing Summary

Andre R. Keijsers, a director of Perfect Moment Ltd. (PMNT), was granted employee stock options totaling 148,958 shares across three option awards. The largest grant—65,758 options—was granted on 10/01/2025 with an exercise price of $0.46, exercisable starting 12/31/2025 and expiring 10/01/2035; that grant vests in four installments (two of 16,440 and two of 16,439) across 12/31/2025 through 09/30/2026. A separate 40,000-option award at $0.48 shows 09/18/2025 with an expiration of 09/17/2035. An earlier 43,200-option award at $4.10 from 10/25/2024 expires 03/04/2034. The Form 4 is filed individually by Keijsers and reflects these non-derivative and derivative option holdings reported as direct ownership.

Positive

• Director alignment: Grants tie director compensation to long‑term share performance with vesting through 09/30/2026
• Retention-focused vesting: Largest award vests in four installments, supporting continuity over the next year

Negative

• Potential dilution: Up to 148,958 shares could be issued if all options are exercised
• Near-term vesting: 16,440 options become exercisable on 12/31/2025, which could increase share count within 12 months

Insights

Compensation & Corporate Governance Analyst

Director received multi‑year option awards totaling 148,958 shares with staged vesting.

The option grants align the director's pay with long‑term shareholder outcomes by tying value to future share price movement over multi‑year vesting and long expirations through 2035. The largest tranche vests in four installments between 12/31/2025 and 09/30/2026, creating retention incentives across the next year.

The main dependences are future stock performance and potential dilution; the grants add 148,958 underlying shares that could convert to common stock if exercised. Monitor outstanding option exercise behavior and reported shares outstanding over the next 12–24 months for dilution impact.

Equity Capital Markets Specialist

Strike prices span $0.46 to $4.10, implying different grant vintages and potential upside if share price rises.

Lower strike prices on the recent grants ($0.46 and $0.48) reflect current award terms and set a break‑even threshold for value capture. The older $4.10 award remains outstanding and may be underwater or in‑the‑money depending on current market price.

Watch reported market price relative to these strikes and any near‑term exercises; exercise activity over the next 12 months will determine cash proceeds to the company and actual share dilution timing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Keijsers Andre Ruben

(Last) (First) (Middle)

244 FIFTH AVENUE

SUITE 1219

(Street)

NEW YORK NY 10001

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Perfect Moment Ltd. [ PMNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Options (right to buy)(1)	$0.46	10/01/2025		A		65,758		12/31/2025(2)	10/01/2035	Common Stock	65,758	(3)	65,758	D
Employee Stock Options (right to buy)(1)	$0.48							09/18/2025(2)	09/17/2035	Common Stock	40,000		40,000	D
Employee Stock Options (right to buy)(1)	$4.1							10/25/2024	03/04/2034	Common Stock	43,200		43,200	D

Explanation of Responses:

1. Employee stock options (right to buy) ("Options") granted pursuant to Issuer's 2021 Equity Incentive Plan, as amended.

2. Options vest and are exercisable as follows: 16,440 Options on December 31, 2025 and March 31, 2026, and 16,439 Options on June 30, 2026 and September 30, 2026.

3. Not applicable.

Remarks:

	/s/ Andre R. Keijsers	10/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Perfect Moment (PMNT) director Andre R. Keijsers receive on the Form 4?

The filing reports option awards totaling 148,958 underlying shares across three grants with exercise prices of $0.46, $0.48, and $4.10.

When do the newly reported options begin vesting or become exercisable?

The largest grant of 65,758 options vests in four installments: 12/31/2025, 03/31/2026, 06/30/2026, and 09/30/2026; other grants show exercisable/expiration dates through 09/17/2035 and 03/04/2034.

How many total shares could be issued if all options reported are exercised?

A total of 148,958 common shares are the maximum underlying amount disclosed across the three option awards.

What are the exercise prices for the option grants disclosed by PMNT?

The exercise prices reported are $0.46, $0.48, and $4.10 for the respective option awards.

Does the Form 4 indicate whether the reporting was filed individually or jointly?

The Form 4 is filed by one reporting person; the filer checked the box indicating the form was filed individually.